Edwards Lifesciences
686 hedge funds and large institutions have $17B invested in Edwards Lifesciences in 2016 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 231 increasing their positions, 255 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $21.4B → $17B (-$4.41B)
30% less call options, than puts
Call options by funds: $81M | Put options by funds: $115M
58% less funds holding in top 10
Funds holding in top 10: 33 → 14 (-19)
Holders
686
Holding in Top 10
14
Calls
$81M
Puts
$115M
Top Buyers
| 1 | +$362M | |
| 2 | +$277M | |
| 3 | +$247M | |
| 4 |
MC
Montag & Caldwell
Atlanta,
Georgia
|
+$135M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$80.9M |
Top Sellers
| 1 | -$361M | |
| 2 | -$233M | |
| 3 | -$196M | |
| 4 |
HM
HealthCor Management
New York
|
-$109M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$86.1M |